NanoVibronix is a leading medical device company specializing in low intensity acoustic technology. With a focus on creating innovative medical devices, NanoVibronix utilizes its patented technology to develop miniature transducers that transmit low-frequency, low-intensity ultrasound through flexible surfaces. This breakthrough technology enables the company to provide cost-effective therapeutic ultrasound solutions for various medical applications.

NanoVibronix offers a range of patch-based products, including the PainShield® which is both CE Mark certified and FDA cleared, and the WoundShield®. Additionally, their catheter-based product, the UroShield® device, is CE mark certified. Led by a team of industry experts, NanoVibronix is spearheaded by CEO and Director Brian Murphy, who brings over 25 years of experience in the medical device sector.

The company's Chief Financial Officer, Steve Brown, and Chief Medical Officer, Dr. Harold Jacob, contribute their vast expertise to further drive NanoVibronix's success. Lindsey Harrison, Vice President of Sales, leads the company's sales efforts.

With a commitment to revolutionizing medical solutions, NanoVibronix is at the forefront of advancing patient care and improving therapeutic outcomes